Hui-Min Gong1, Jing Wang2, Jing Xu3, Zhan-Yu Zhou1, Jing-Wen Li1, Shu-Fang Chen4. 1. Ophthalmologic Center, Qingdao Municipal Hospital, the Affiliated Municipal Hospital of Qingdao University, Qingdao 266000, Shandong Province, China. 2. Department of Ophthalmology, Dezhou People's Hospital, Dezhou 253000, Shandong Province, China. 3. Department of Ophthalmology, Weifang People's Hospital, Weifang 261041, Shandong Province, China. 4. Department of Medical Equipment, Weifang People's Hospital, Weifang 261041, Shandong Province, China.
Abstract
AIM: To identify the potentially pathogenic gene variants that contributes to the etiology of strabismus. METHODS: A Chinese pedigree with strabismus was collected and the exomes of two affected individuals were sequenced using the next-generation sequencing technology. The resulting variants from exome sequencing were filtered by subsequent bioinformatics methods and the candidate mutation was verified as heterozygous in the affected proposita and her mother by sanger sequencing. RESULTS: Whole exome sequencing and filtering identified a nonsynonymous mutation c.434G-T transition in paired box 3 (PAX3) in the two affected individuals, which were predicted to be deleterious by more than 4 bioinformatics programs. This altered amino acid residue was located in the conserved PAX domain of PAX3. This gene encodes a member of the PAX family of transcription factors, which play critical roles during fetal development. Mutations in PAX3 were associated with Waardenburg syndrome with strabismus. CONCLUSION: Our results report that the c.434G-T mutation (p.R145L) in PAX3 may contribute to strabismus, expanding our understanding of the causally relevant genes for this disorder.
AIM: To identify the potentially pathogenic gene variants that contributes to the etiology of strabismus. METHODS: A Chinese pedigree with strabismus was collected and the exomes of two affected individuals were sequenced using the next-generation sequencing technology. The resulting variants from exome sequencing were filtered by subsequent bioinformatics methods and the candidate mutation was verified as heterozygous in the affected proposita and her mother by sanger sequencing. RESULTS: Whole exome sequencing and filtering identified a nonsynonymous mutation c.434G-T transition in paired box 3 (PAX3) in the two affected individuals, which were predicted to be deleterious by more than 4 bioinformatics programs. This altered amino acid residue was located in the conserved PAX domain of PAX3. This gene encodes a member of the PAX family of transcription factors, which play critical roles during fetal development. Mutations in PAX3 were associated with Waardenburg syndrome with strabismus. CONCLUSION: Our results report that the c.434G-T mutation (p.R145L) in PAX3 may contribute to strabismus, expanding our understanding of the causally relevant genes for this disorder.
Authors: Vaishali Parikh; Yin Yao Shugart; Kimberly F Doheny; Jie Zhang; Lan Li; John Williams; David Hayden; Brian Craig; Hilda Capo; Denise Chamblee; Cathy Chen; Mary Collins; Stuart Dankner; Dean Fiergang; David Guyton; David Hunter; Marcia Hutcheon; Marshall Keys; Nancy Morrison; Michelle Munoz; Marshall Parks; David Plotsky; Eugene Protzko; Michael X Repka; Maria Sarubbi; Bruce Schnall; R Michael Siatkowski; Elias Traboulsi; Joanne Waeltermann; Jeremy Nathans Journal: Proc Natl Acad Sci U S A Date: 2003-09-30 Impact factor: 11.205
Authors: Dandi Qiao; Christoph Lange; Nan M Laird; Sungho Won; Craig P Hersh; Jarrett Morrow; Brian D Hobbs; Sharon M Lutz; Ingo Ruczinski; Terri H Beaty; Edwin K Silverman; Michael H Cho Journal: Genet Epidemiol Date: 2017-02-13 Impact factor: 2.135
Authors: J Khan; M L Bittner; L H Saal; U Teichmann; D O Azorsa; G C Gooden; W J Pavan; J M Trent; P S Meltzer Journal: Proc Natl Acad Sci U S A Date: 1999-11-09 Impact factor: 11.205
Authors: Aine Rice; Jérémie Nsengimana; Ian G Simmons; Carmel Toomes; Janice Hoole; Colin E Willoughby; Frances Cassidy; Grange A Williams; Nick D George; Eamonn Sheridan; Terri L Young; Tim I Hunter; Brendan T Barrett; David B Elliott; D Tim Bishop; Chris F Inglehearn Journal: Invest Ophthalmol Vis Sci Date: 2009-02-14 Impact factor: 4.799
Authors: L A Farrer; K S Arnos; J H Asher; C T Baldwin; S R Diehl; T B Friedman; J Greenberg; K M Grundfast; C Hoth; A K Lalwani Journal: Am J Hum Genet Date: 1994-10 Impact factor: 11.025